天博体育app下载官网

岗位职责

• Responsible for deal due diligence and evaluation
• Support Managing Partner / Partner on due diligence (including market research, product / service feasibility and financial analysis), deal execution and portfolio management 
• Assist in the preparation and presentation of investment memo to investment committee
• Conduct industry research on specific healthcare areas
• Assist with networking efforts within VC and entrepreneurship communities

任职要求

• Graduated from one of top medical university with MD or PhD. Degree or MBA in US or China
• R&D and/or product experience with multinational pharma or health care company favorable Entrepreneurship experience a plus
• Deep passion for health care sector
• Strong analytical skill
• Strong communication and presentation skill 
• Fluent in written and spoken English and Chinese

关于天博体育app下载官网

 Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Shenzhen, Hong Kong, Seattle, Boston and the San Francisco Bay Area.

 

Currently Qiming Venture Partners manages nine US Dollar funds and six RMB funds with $5.9 billion in assets under management. Since our establishment, we have invested in outstanding companies in the TMT and healthcare industries at the early and growth stages.

 

Since our debut, we have backed over 380 fast-growing and innovative companies. Over 130 companies are already listed on NYSE, NASDAQ, HKEx, Gretai Securities Market, Shanghai Stock Exchange and Shenzhen Stock Exchange, or achieved exit through M&A and other means. There are also over 40 portfolio companies that have achieved unicorn status.

 

Many of our portfolio companies are today's most influential firms in their respective sectors, including Xiaomi (SEHK:1810), Meituan (SEHK:3690), Bilibili (NASDAQ:BILI), Roborock (SHSE:688169), Gan & Lee Pharmaceuticals (SHSE: 603087), Tigermed (SZSE:300347, SEHK:3347), New Horizon Health (SEHK:6606), Zai Lab (NASDAQ:ZLAB, SEHK:9688), Venus MedTech (SEHK:2500), CanSino Biologics (SEHK:6185, SHSE:688185), Schrödinger (NASDAQ:SDGR), APT Medical (SHSE:688617), Sanyou Medical (SHSE:688085), AmoyDx (SZSE:300685), Berry Genomics (SZSE:000710), SinocellTech (SHSE: 688520), WeDoctor Group, and UBTech among many others.

 

 

求职邮箱

 Please contact Qiming Human Resources Department at to submit your resume.